CEPED, IRD-University of Paris, ERL INSERM SAGESUD, Paris, France.
Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.
Hum Vaccin Immunother. 2021 Nov 2;17(11):3907-3912. doi: 10.1080/21645515.2021.1951097. Epub 2021 Jul 19.
This research aims to understand the level and determinants of people's willingness to participate in a vaccine trial for COVID-19 in Senegal. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years of age. Only 44.3% of the participants wanted to participate in a vaccine trial for COVID-19, with females intending to participate more than males (AOR = 1.82, 95% CI [1.22-2.72]). Participants who intended to be vaccinated against COVID-19 (AOR = 6.48, 95% CI [4.12-10.4]) and who thought that being infected with the coronavirus would have a significant impact on their health (AOR = 2.34, 95% CI [1.57, 3.51]) were more likely to agree to take part in the COVID-19 vaccine trial. Confidence in the vaccine, health personnel, and the government in the fight against the pandemic are key factors in participants' willingness to participate in a vaccine trial in Senegal.
本研究旨在了解塞内加尔民众对参与 COVID-19 疫苗试验的意愿水平和决定因素。我们对 607 名 18 岁以上的边缘配额样本进行了电话调查。只有 44.3%的参与者表示愿意参加 COVID-19 疫苗试验,女性比男性更愿意参加(AOR=1.82,95%CI[1.22-2.72])。打算接种 COVID-19 疫苗的参与者(AOR=6.48,95%CI[4.12-10.4])和认为感染冠状病毒会对其健康产生重大影响的参与者(AOR=2.34,95%CI[1.57,3.51])更有可能同意参加 COVID-19 疫苗试验。对疫苗、卫生人员和政府在抗击大流行方面的信心是参与者愿意在塞内加尔参加疫苗试验的关键因素。